KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Other Accumulated Expenses (2016 - 2025)

Colgate Palmolive (CL) has 17 years of Other Accumulated Expenses data on record, last reported at $3.3 billion in Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 12.9% year-over-year to $3.3 billion; the TTM value through Dec 2025 reached $3.3 billion, up 12.9%, while the annual FY2025 figure was $3.3 billion, 12.9% up from the prior year.
  • Other Accumulated Expenses reached $3.3 billion in Q4 2025 per CL's latest filing, up from $3.2 billion in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $3.3 billion in Q4 2025 and bottomed at $2.1 billion in Q4 2021.
  • Average Other Accumulated Expenses over 5 years is $2.7 billion, with a median of $2.6 billion recorded in 2021.
  • Peak YoY movement for Other Accumulated Expenses: dropped 10.94% in 2021, then increased 21.62% in 2024.
  • A 5-year view of Other Accumulated Expenses shows it stood at $2.1 billion in 2021, then rose by 1.25% to $2.1 billion in 2022, then grew by 12.6% to $2.4 billion in 2023, then grew by 21.62% to $2.9 billion in 2024, then increased by 12.9% to $3.3 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $3.3 billion in Q4 2025, $3.2 billion in Q3 2025, and $3.1 billion in Q2 2025.